Tristar Bone Marrow Transplant is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
Tristar Bone Marrow Transplant has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Chronic Graft-Versus-Host Disease (cGVHD), Acute Myeloid Leukemia (AML), Leukemia.
Sponsors: Deciphera Pharmaceuticals, LLC, K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc., Daiichi Sankyo.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Tristar Bone Marrow Transplant has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Tristar Bone Marrow Transplant has 3 clinical trials on record, with 2 currently active. Their work covers Chronic Graft-Versus-Host Disease (cGVHD), Acute Myeloid Leukemia (AML), Leukemia.
Tristar Bone Marrow Transplant has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.